Addex Therapeutics Ltd financials at a glance

+ Portfolio

The revenue of Addex Therapeutics Ltd is reported as 0.00165 billion Switzerland Francs in the fiscal year 2023. The earnings were -0.14 Switzerland Francs per share in 2023, which was 69.57 higher than 2022. And about -0.01386 billion Switzerland Francs are reported as free cash flow in the financials of Addex Therapeutics Ltd 2023. No dividends were paid to the shareholders of the Addex Therapeutics Ltd stock SWX:ADXN in the financial year 2023.

CHF1.65M

Revenue

CHF-0.14

Earnings Per Share

100.00%

Gross Margin %

CHF-5.40M

Free Cash Flow

Revenue

1.65

Earnings Per Share

-0.14

Gross Margin %

100.00

Free Cash Flow

-5.40

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2013	2012	2011	2010	2009	2008	2007
Rev.	Revenue	N/A	CHF1.65M	CHF1.45M	CHF3.15M	CHF3.88M	CHF2.76M	CHF0.00M	CHF0.50M	CHF0.41M	CHF0.14M	CHF0.12M	CHF3.74M	CHF4.00M	CHF4.50M	CHF26.87M	CHF0.64M
GM %	Gross Margin %	-,275.12%	100.00%	0.00%	0.00%	-,166.79%	-,229.98%	64.66%	-68.30%	-98.99%	0.00%	0.00%	-27.15%	-18.42%	-,185.51%	19.88%	0.00%
OM	Operating Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-21.25%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-92.55%	0.00%
EPS	Earnings Per Share	CHF-0.17	CHF-0.14	CHF-0.46	CHF-0.45	CHF-0.48	CHF-0.56	CHF-0.07	CHF-0.25	CHF-0.28	CHF-1.60	CHF-3.41	CHF-4.19	CHF-5.69	CHF-7.44	CHF-3.85	CHF-4.37
Div.	Dividends	N/A	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00	CHF0.00
PR %	Payout Ratio %	0	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%	0	0	0	0	-0.00%	-0.00%	-0.00%	-0.00%	-0.00%
Sha.	Shares	N/AM	128.26M	80.88M	37.9M	27.12M	26.61M	26.41M	13.42M	11.56M	9.84M	8.63M	7.71M	6.33M	5.74M	5.74M	5.74M
OCF	Operating Cash Flow	N/A	CHF-11.30M	CHF-16.44M	CHF-14.71M	CHF-12.18M	CHF-9.48M	CHF0.00M	CHF-2.13M	CHF0.00M	CHF0.00M	CHF-29.45M	CHF-26.55M	CHF-31.34M	CHF-39.38M	CHF-17.79M	CHF-33.00M
FCF	Free Cash Flow	N/A	CHF-5.40M	CHF-16.44M	CHF-14.74M	CHF-12.24M	CHF-9.51M	CHF0.00M	CHF-2.13M	CHF0.00M	CHF0.00M	CHF-29.67M	CHF-26.74M	CHF-31.75M	CHF-43.52M	CHF-23.28M	CHF-35.56M
FCFS	Free Cash Flow Per Share	CHF-0.16	CHF-0.11	CHF-0.36	CHF-0.43	CHF-0.46	CHF-0.36	CHF0.07	CHF-0.17	CHF-0.24	CHF-1.74	CHF-3.76	CHF-3.60	CHF-5.37	CHF-7.60	CHF-4.08	CHF-7.12

Addex Therapeutics Ltd financials at a glance

Financials

Discover